Search

Subject APL -- ATRA plus ATO -- MRD monitoring

1. Value of measurable residual disease monitoring in patients with acute promyelocytic leukemia in the era of frontline 'chemotherapy-free' therapy. Issue 3 (23rd February 2022)

Authors:
Ramos Perez, Jorge M.; Patel, Keyur P.; Loghavi, Sanam; Garcia-Manero, Guillermo; Borthakur, Gautam; Jabbour, Elias; Wierda, William; Pierce, Sherry; Brandt, Mark; Kornblau, Steven; Kadia, Tapan; Daver, Naval; DiNardo, Courtney D.; Jain, Nitin; Yilmaz, Musa; Short, Nicholas; Verstovsek, Srdan; Fe...
Journal:
Leukemia & lymphoma
Issue:
Volume 63:Issue 3(2022)
Page Start:
672
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search

  • APL -- ATRA plus ATO -- MRD monitoring 1